Observational Study of Perspectives of Inflammatory Bowel Disease Patients Concerning the Use of Corticosteroids

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Digestive Diseases

• Publication date

  2017-09-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000478772PMID 28866661
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Management of acute severe ulcerative colitis.

  2014cited by this paper
• Assessing Patient Preferences for Treatment Options and Process of Care in Inflammatory Bowel Disease: A Critical Review of Quantitative Data

  2013cited by this paper
• Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management.

  2012cited by this paper
• Current and emerging drugs for the treatment of inflammatory bowel disease

  2011cited by this paper
• Cost Effectiveness of Treatments for Inflammatory Bowel Disease

  2011cited by this paper
• Immediate and long‐term outcomes of corticosteroid therapy in pediatric crohn's disease patients

  2011cited by this paper
• History of the development of corticosteroid therapy.

  2011cited by this paper
• Review article: appropriate use of corticosteroids in Crohn’s disease

  2007cited by this paper
• The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5‐year UK inception cohort

  2006cited by this paper
• Predictors of Crohn's disease.

  2006cited by this paper
• Review article: altering the natural history of Crohn's disease – evidence for and against current therapies

  2006cited by this paper
• Predictors of Crohn's disease.

  2006cited by this paper
• Assessment of mood states in patients receiving long-term corticosteroid therapy and in controls with patient-rated and clinician-rated scales.

  2004cited by this paper
• Treatment of inflammatory bowel disease with corticosteroids.

  2004cited by this paper
• Treatment of inflammatory bowel disease: safety and tolerability issues.

  2003cited by this paper
• The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study.

  2001cited by this paper
• Mood and Cognitive Changes During Systemic Corticosteroid Therapy.

  2001cited by this paper
• Side Effects of Corticosteroid Therapy

  2001cited by this paper
• A simple clinical colitis activity index

  1998cited by this paper
• Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives.

  1992cited by this paper
• Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives.

  1990cited by this paper
• Advances in drug therapy for inflammatory bowel disease.

  1990cited by this paper
• A simple index of Crohn's-disease activity.

  1980cited by this paper

• Sources of excess steroid prescriptions and clinical adverse outcomes associated with steroid excess in patients with inflammatory bowel disease: The Leeds IBD Steroids study

  2022cites this paper
• Perspectives on Treatment of Inflammatory Bowel Disease in Older Patients: Applying Gut-Feeling in an Evidence-Based Era?

  2022cites this paper
• The Patients' Perspective of Important Glucocorticoid Effects

  2020cites this paper
• The patient's perspective of the adverse effects of glucocorticoid use: A systematic review of quantitative and qualitative studies. From an OMERACT working group.

  2020cites this paper
• Protective effect of three glucomannans from different plants against DSS induced colitis in female BALB/c mice.

  2019cites this paper
• Patients Perception of Risks and Benefits of Biologic Therapy.

  2019cites this paper